BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15367169)

  • 1. Publication of clinical trials: accountability and accessibility.
    Tumber MB; Dickersin K
    J Intern Med; 2004 Oct; 256(4):271-83. PubMed ID: 15367169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haunted manuscripts: ghost authorship in the medical literature.
    Ngai S; Gold JL; Gill SS; Rochon PA
    Account Res; 2005; 12(2):103-14. PubMed ID: 16220624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On transparency, responsibility, and accountability.
    Paul M
    Clin Microbiol Infect; 2009 Dec; 15(12):1100-2. PubMed ID: 19929974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Module six: special issues.
    Schneider B; Schüklenk U
    Dev World Bioeth; 2005 Mar; 5(1):92-108. PubMed ID: 15748180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New author guidelines - clinical trials and conflict of interest.
    Foster A
    Vet Dermatol; 2008 Apr; 19(2):51. PubMed ID: 18336420
    [No Abstract]   [Full Text] [Related]  

  • 12. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An author's guide to publication ethics: a review of emerging standards in biomedical journals.
    Roberts J
    Headache; 2009 Apr; 49(4):578-89. PubMed ID: 19338617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews.
    Turpin DL
    Am J Orthod Dentofacial Orthop; 2005 Dec; 128(6):681-5; discussion 686. PubMed ID: 16360902
    [No Abstract]   [Full Text] [Related]  

  • 15. Ghost authorship in industry-initiated randomised trials.
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    PLoS Med; 2007 Jan; 4(1):e19. PubMed ID: 17227134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific authorship. Part 2. History, recurring issues, practices, and guidelines.
    Claxton LD
    Mutat Res; 2005 Jan; 589(1):31-45. PubMed ID: 15652225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
    Ioannidis JP
    Arch Intern Med; 2009 Oct; 169(19):1737-9. PubMed ID: 19858427
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of data, authorship, and responsibility for clinical trials publications.
    Freeman WR
    Ophthalmology; 2005 Sep; 112(9):1485-6. PubMed ID: 16139664
    [No Abstract]   [Full Text] [Related]  

  • 20. [More stringent requirements concerning manuscripts. Declarations of potential connections and conflicts of interest published in the Lakartidningen].
    Milerad J; Ahlberg J; Eliasson M; Fridén B; Håkansson A; Sundberg CJ; Agren H; Ostergren J
    Lakartidningen; 2002 Apr; 99(15):1662-3. PubMed ID: 12025190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.